If you've been diagnosed with Peripheral Artery Disease (P.A.D.), it's important to learn about the increased risk for heart attack or stroke associated with P.A.D. Having P.A.D. more than doubles your risk of heart attack or stroke. In fact, it puts you at more than 4 times the risk of dying from heart disease such as heart attack or stroke.

You may be taking other medicines to lower your cholesterol or blood pressure. Although these medicines are important and can help reduce your overall cardiovascular risk, there may be more you can do.

Blood clots cause over 90% of heart attacks and 85% of strokes. Plavix® (clopidogrel bisulfate) has been proven to help keep platelets in the blood from sticking together and forming clots. This helps keep blood flowing and helps protect you from a future heart attack or stroke. PLAVIX is the only prescription antiplatelet therapy that is FDA-approved for patients with Peripheral Artery Disease to help reduce the risk of heart attack and stroke. For over 11 years, PLAVIX has been prescribed to over 91 million patients to help reduce the risk of heart attack or stroke. That's why it's important to talk to your doctor about PLAVIX.

Remember to consult with your doctor with any questions or concerns regarding your health, or before beginning any sort of exercise or change in your diet.

Learn more about P.A.D.

PLAVIX is prescribed to lower the risk of future heart attack or stroke in patients with established Peripheral Artery Disease.

Important Safety Information: People with stomach ulcers or other conditions that cause bleeding should not use PLAVIX. Taking PLAVIX alone or with some other medicines, including aspirin, may increase bleeding risk, so tell your doctor when planning surgery. Certain genetic factors and some medicines, such as Prilosec, may affect how PLAVIX works. Tell your doctor all the medicines you take, including aspirin, especially if you’ve had a stroke. If fever, unexplained weakness or confusion develops, tell your doctor promptly. These may be signs of TTP, a rare but potentially life-threatening condition, reported sometimes less than 2 weeks after starting PLAVIX. Other rare but serious side effects may occur.

Please see full prescribing information for more details.

The health information contained herein is provided for general educational
purposes only. Your health-care professional is the single best source of
information regarding your health. Please consult your health-care professional if
you have any questions about your health or treatment.